GoodRx Holdings [GDRX] vs Teladoc Health [TDOC] Detailed Stock Comparison

GoodRx Holdings Inc.

NASDAQ
Loading...

Teladoc Health Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: GoodRx Holdings Inc. wins in 10 metrics, Teladoc Health Inc. wins in 8 metrics, with 0 ties. GoodRx Holdings Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric GoodRx Holdings Inc. Teladoc Health Inc. Better
P/E Ratio (TTM) 25.67 N/A N/A
Price-to-Book Ratio 1.28 0.74 Teladoc Health Inc.
Debt-to-Equity Ratio 88.08 75.06 Teladoc Health Inc.
PEG Ratio 6.29 -6.16 GoodRx Holdings Inc.
EV/EBITDA 8.77 38.86 GoodRx Holdings Inc.
Profit Margin (TTM) 3.82% -7.92% GoodRx Holdings Inc.
Operating Margin (TTM) 18.98% -4.20% GoodRx Holdings Inc.
EBITDA Margin (TTM) 18.98% N/A N/A
Return on Equity 4.54% -13.93% GoodRx Holdings Inc.
Return on Assets (TTM) 4.75% -3.20% GoodRx Holdings Inc.
Free Cash Flow (TTM) $93.88M $137.33M Teladoc Health Inc.
1-Year Return -25.51% 9.97% Teladoc Health Inc.
Price-to-Sales Ratio (TTM) 0.99 0.41 Teladoc Health Inc.
Enterprise Value $1.07B $1.28B Teladoc Health Inc.
EV/Revenue Ratio 1.35 0.51 Teladoc Health Inc.
Gross Profit Margin (TTM) 91.03% 69.32% GoodRx Holdings Inc.
Revenue per Share (TTM) $2 $14 Teladoc Health Inc.
Earnings per Share (Diluted) $0.09 $-34.20 GoodRx Holdings Inc.
Beta (Stock Volatility) 1.47 2.08 GoodRx Holdings Inc.
Short % of Float 8.92% 16.55% GoodRx Holdings Inc.

GoodRx Holdings Inc. vs Teladoc Health Inc. Stock Performance Analysis

Loading Price Chart...

GDRX
TDOC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
GoodRx Holdings Inc.-4.75%-1.75%12.40%35.75%2.55%2.18%
Teladoc Health Inc.-5.97%7.59%6.94%39.02%-5.84%0.57%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
GoodRx Holdings Inc.-25.51%-45.83%-92.39%-94.39%-94.39%-94.39%
Teladoc Health Inc.9.97%-68.91%-94.81%-35.62%-72.82%-72.82%

Performance & Financial Health Analysis: GoodRx Holdings Inc. vs Teladoc Health Inc.

MetricGDRXTDOC
Market Information
Market Cap i$787.92M$1.04B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,461,8254,716,750
90 Day Avg. Volume i1,623,3254,439,277
Last Close$2.81$7.09
52 Week Range$1.77 - $5.81$4.40 - $9.77
% from 52W High-51.64%-27.43%
All-Time High$64.22 (Sep 28, 2020)$308.00 (Feb 15, 2021)
% from All-Time High-95.62%-97.70%
Growth Metrics
Quarterly Revenue Growth-0.02%0.00%
Quarterly Earnings Growth-0.20%0.00%
Financial Health
Profit Margin (TTM) i0.04%-0.08%
Operating Margin (TTM) i0.19%-0.04%
Return on Equity (TTM) i0.05%-0.14%
Debt to Equity (MRQ) i88.0875.06
Cash & Liquidity
Book Value per Share (MRQ)$1.81$7.77
Cash per Share (MRQ)$0.76$4.38
Operating Cash Flow (TTM) i$167.90M$294.36M
Levered Free Cash Flow (TTM) i$81.94M$226.14M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: GoodRx Holdings Inc. vs Teladoc Health Inc.

MetricGDRX (Apr 24, 2026)TDOC (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i25.67N/A
Forward P/E i6.29-6.16
PEG Ratio i6.29-6.16
Price to Sales (TTM) i0.990.41
Price to Book (MRQ) i1.280.74
Market Capitalization
Market Capitalization i$787.92M$1.04B
Enterprise Value i$1.07B$1.28B
Enterprise Value Metrics
Enterprise to Revenue i1.350.51
Enterprise to EBITDA i8.7738.86
Risk & Other Metrics
Beta i1.472.08
Book Value per Share (MRQ) i$1.81$7.77

Financial Statements Comparison: GoodRx Holdings Inc. vs Teladoc Health Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricGDRX (2025)TDOC (2025)
Revenue/Sales i796.85M2.53B
Cost of Goods Sold i57.60M771.59M
COGS % of Revenue i7.2%30.5%
Gross Profit i739.26M1.76B
Gross Margin i92.8%69.5%
Research & Development i121.03M277.92M
Operating Income (EBIT) i87.49M-163.40M
Operating Margin i11.0%-6.5%
EBITDA i184.36M260.18M
EBITDA Margin i23.1%10.3%
Pre-Tax Income i56.54M-235.53M
Pre-Tax Income % of Revenue i7.1%-9.3%
Income Tax i26.10M-35.21M
Income Tax % of Revenue i3.3%-1.4%
Net Income (Profit) i30.44M-200.32M
Profit Margin i3.8%-7.9%

Balance Sheet & Liquidity Metrics

MetricGDRX (2025)TDOC (2025)
Cash & Equivalents i261.82M781.08M
Total Current Assets i643.10M1.12B
Total Current Assets % of Revenue i80.7%44.2%
Total Current Liabilities i246.00M404.74M
Total Current Liabilities % of Revenue i30.9%16.0%
Long-Term Debt i533.05M1.03B
Long-Term Debt % of Revenue i66.9%40.7%
Total Shareholders Equity i616.26M1.39B
Retained Earnings i-1.41B-16.43B
Retained Earnings % of Revenue i-177.0%-649.4%
Property, Plant & Equipment i28.81M42.03M

Cash Flow Statement Comparison

MetricGDRX (2025)TDOC (2025)
Operating Cash Flow i170.70M225.59M
Operating Cash Flow % of Revenue i21.4%8.9%
Capital Expenditures i-3.52MN/A
Free Cash Flow i93.88M137.33M
FCF Margin i11.8%5.4%
Debt Repayment i-5.00M-550.63M
Common Stock Repurchase i-216.37MN/A

Short Interest & Institutional Ownership Analysis

MetricGDRXTDOC
Shares Short i8.69M29.71M
Short Ratio i3.146.89
Short % of Float i8.92%16.55%
Shares Outstanding i341.05M178.32M
Float Shares i95.34M176.23M
% Held by Insiders i12.57%0.65%
% Held by Institutions i58.17%75.86%
% Held by Public i29.26%23.49%

Dividend Analysis & Yield Comparison: GoodRx Holdings Inc. vs Teladoc Health Inc.

MetricGDRXTDOC
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A